These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35704373)
1. Factors associated with pancreatic cancer in Spain. What can we learn from epidemiological studies? Marra-López Valenciano C Rev Esp Enferm Dig; 2022 Aug; 114(8):445-447. PubMed ID: 35704373 [TBL] [Abstract][Full Text] [Related]
2. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival. Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422 [TBL] [Abstract][Full Text] [Related]
4. Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis. Munigala S; Subramaniam DS; Subramaniam DP; Burroughs TE; Conwell DL; Sheth SG Dig Dis Sci; 2022 Feb; 67(2):708-715. PubMed ID: 33630214 [TBL] [Abstract][Full Text] [Related]
5. Modifiable and non-modifiable risk factors for pancreatic cancer: A review. Midha S; Chawla S; Garg PK Cancer Lett; 2016 Oct; 381(1):269-77. PubMed ID: 27461582 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and risk factors of pancreatic cancer. Capasso M; Franceschi M; Rodriguez-Castro KI; Crafa P; Cambiè G; Miraglia C; Barchi A; Nouvenne A; Leandro G; Meschi T; De' Angelis GL; Di Mario F Acta Biomed; 2018 Dec; 89(9-S):141-146. PubMed ID: 30561407 [TBL] [Abstract][Full Text] [Related]
7. Association between chronic pancreatitis and pancreatic cancer: A 10-year retrospective study of endoscopically treated and surgical patients. Korpela T; Udd M; Mustonen H; Ristimäki A; Haglund C; Seppänen H; Kylänpää L Int J Cancer; 2020 Sep; 147(5):1450-1460. PubMed ID: 32162688 [TBL] [Abstract][Full Text] [Related]
8. Demographics and epidemiology of pancreatic cancer. Yeo TP; Lowenfels AB Cancer J; 2012; 18(6):477-84. PubMed ID: 23187833 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ; Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848 [TBL] [Abstract][Full Text] [Related]
11. Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: A cohort of 1656 patients. Hao L; Zeng XP; Xin L; Wang D; Pan J; Bi YW; Ji JT; Du TT; Lin JH; Zhang D; Ye B; Zou WB; Chen H; Xie T; Li BR; Zheng ZH; Wang T; Guo HL; Liao Z; Li ZS; Hu LH Dig Liver Dis; 2017 Nov; 49(11):1249-1256. PubMed ID: 28756974 [TBL] [Abstract][Full Text] [Related]
12. Using the Risk Factors of Pancreatic Cancer and Their Interactions in Cancer Screening: A Case-Control Study in Shanghai, China. Bo X; Shi J; Liu R; Geng S; Li Q; Li Y; Jin H; Yang S; Jiang H; Wang Z Ann Glob Health; 2019 Jul; 85(1):. PubMed ID: 31298822 [TBL] [Abstract][Full Text] [Related]
13. Factors influencing mortality trends of pancreatic cancer in Spain, 1955-2020. Gili Ortiz E Rev Esp Enferm Dig; 2022 Aug; 114(8):474-480. PubMed ID: 35548865 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic Cancer: A Review. Yabar CS; Winter JM Gastroenterol Clin North Am; 2016 Sep; 45(3):429-45. PubMed ID: 27546841 [TBL] [Abstract][Full Text] [Related]
16. The role of inflammation in pancreatic cancer. Hausmann S; Kong B; Michalski C; Erkan M; Friess H Adv Exp Med Biol; 2014; 816():129-51. PubMed ID: 24818722 [TBL] [Abstract][Full Text] [Related]
17. Pancreaticoduodenectomy in the Elderly Patient: Age-Adapted Risk Assessment. Wiltberger G; Muhl B; Benzing C; Hau HM; Bartels M; Krenzien F Dig Surg; 2017; 34(1):43-51. PubMed ID: 27434057 [TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. Liao KF; Lai SW; Li CI; Chen WC J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650 [TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome components and risk factors for pancreatic adenocarcinoma: a case-control study in China. Wu Q; Chen G; Wu WM; Zhou L; You L; Zhang TP; Zhao YP Digestion; 2012; 86(4):294-301. PubMed ID: 23095334 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables. Scholten L; Latenstein AE; Aalfs CM; Bruno MJ; Busch OR; Bonsing BA; Koerkamp BG; Molenaar IQ; Ubbink DT; van Hooft JE; Fockens P; Glas J; DeVries JH; Besselink MG; United European Gastroenterol J; 2020 Oct; 8(8):865-877. PubMed ID: 32703081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]